Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
1,150.41
1,355.34
1,803.24
1,385.80
1,111.70
957.37
675.36
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,150.41
1,355.34
1,803.24
1,385.80
1,111.70
957.37
675.36
Raw Material Cost
426.63
514.12
684.91
513.73
434.47
279.19
158.62
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
15.42
17.48
17.15
15.99
7.17
1.65
0.12
Selling and Distribution Expenses
327.61
416.78
389.78
308.07
258.19
233.92
199.66
Other Expenses
15.53
18.92
19.79
14.05
10.71
9.95
7.80
Total Expenditure (Excl Depreciation)
924.93
1,137.54
1,289.75
978.29
806.92
614.25
436.38
Operating Profit (PBDIT) excl Other Income
225.5
217.8
513.5
407.5
304.8
343.1
239
Other Income
85.31
113.33
79.72
62.57
52.72
51.85
47.70
Operating Profit (PBDIT)
370.88
416.64
636.21
526.79
400.33
427.11
315.15
Interest
15.42
17.48
17.15
15.99
7.17
1.65
0.12
Exceptional Items
-0.20
10.25
18.34
-4.68
24.41
4.33
0.00
Gross Profit (PBDT)
723.79
841.23
1,118.33
872.07
677.23
678.18
516.74
Depreciation
99.45
101.85
78.14
56.53
41.95
33.64
27.76
Profit Before Tax
255.81
307.56
559.26
449.59
375.62
396.14
287.27
Tax
23.55
20.86
56.03
39.62
43.73
46.02
36.63
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
223.64
279.77
498.91
398.99
304.73
339.67
249.61
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
223.64
279.77
498.91
398.99
304.73
339.67
249.61
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
6.24
4.31
5.03
13.02
25.58
10.27
1.03
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
229.88
284.08
503.94
412.01
330.31
349.95
250.64
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,618.96
2,559.32
2,482.47
2,106.40
1,837.99
1,624.97
1,350.26
Earnings per share (EPS)
0.44
0.55
0.98
0.79
0.6
0.66
0.49
Diluted Earnings per share
0.44
0.55
0.98
0.79
0.6
0.66
0.49
Operating Profit Margin (Excl OI)
16.18%
14.86%
26.53%
29.42%
27.5%
35.68%
35.49%
Gross Profit Margin
30.88%
30.21%
35.35%
36.52%
37.56%
44.89%
46.65%
PAT Margin
19.44%
20.64%
27.67%
28.79%
27.41%
35.48%
36.96%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is -15.12% vs -24.84% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is -19.08% vs -43.62% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is -5.84% vs -45.50% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is -12.00% vs 2.34% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Getein Biotech, Inc. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
1,150.41
0
1,150.41
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,150.41
0
1,150.41
Raw Material Cost
426.63
0
426.63
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
15.42
0
15.42
Selling and Distribution Expenses
327.61
0
327.61
Other Expenses
15.53
0.00
15.53
Total Expenditure (Excl Depreciation)
924.93
0
924.93
Operating Profit (PBDIT) excl Other Income
225.48
0.00
225.48
Other Income
85.31
0
85.31
Operating Profit (PBDIT)
370.88
0
370.88
Interest
15.42
0
15.42
Exceptional Items
-0.20
0
-0.20
Gross Profit (PBDT)
723.79
0
723.79
Depreciation
99.45
0
99.45
Profit Before Tax
255.81
0
255.81
Tax
23.55
0
23.55
Provisions and contingencies
0
0
0.00
Profit After Tax
223.64
0
223.64
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
223.64
0
223.64
Share in Profit of Associates
0
0
0.00
Minority Interest
6.24
0
6.24
Other related items
0.00
0.00
0.00
Consolidated Net Profit
229.88
0
229.88
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,618.96
0
2,618.96
Earnings per share (EPS)
0.44
0
0.44
Diluted Earnings per share
0.44
0
0.44
Operating Profit Margin (Excl OI)
16.18%
0%
0.00
16.18%
Gross Profit Margin
30.88%
0%
0.00
30.88%
PAT Margin
19.44%
0%
0.00
19.44%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 115.04 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -15.12% vs -24.84% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 22.99 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -19.08% vs -43.62% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 28.56 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -5.84% vs -45.50% in Dec 2023
Annual - Interest
Interest 1.54 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -12.00% vs 2.34% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.18%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






